Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes
NCT ID: NCT03164668
Last Updated: 2024-07-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2017-05-03
2019-11-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette Use
NCT03402243
Smoking Cessation in Menthol Flavored Cigarette Smokers
NCT02342327
Effects of Menthol in E-cigarettes on Smoking Behaviors
NCT04521647
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
NCT05555069
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2
NCT03168191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual cigs; menthol e-cig then tobacco e-cigs
Participants can continue to smoke their usual cigarettes. For the first month of study they receive menthol flavored e-cigarettes and for the second month they receive tobacco flavored e-cigarettes
menthol flavored e-cigarette
menthol flavored e-cigarette
tobacco flavored e-cigarette
tobacco flavored e-cigarette
Usual cigs; tobacco e-cig then menthol e-cigs
Participants can continue to smoke their usual cigarettes. For the first month of study they receive tobacco flavored e-cigarettes and for the second month they receive menthol flavored e-cigarettes
menthol flavored e-cigarette
menthol flavored e-cigarette
tobacco flavored e-cigarette
tobacco flavored e-cigarette
avoid menthol cigs; menthol e-cig then tobacco e-cigs
Participants avoid smoking menthol cigarettes. For the first month of study they receive menthol flavored e-cigarettes and for the second month they receive tobacco flavored e-cigarettes
menthol flavored e-cigarette
menthol flavored e-cigarette
tobacco flavored e-cigarette
tobacco flavored e-cigarette
avoid menthol cigs; tobacco e-cig then menthol e-cigs
Participants avoid smoking menthol cigarettes. For the first month of study they receive tobacco flavored e-cigarettes and for the second month they receive menthol flavored e-cigarettes
menthol flavored e-cigarette
menthol flavored e-cigarette
tobacco flavored e-cigarette
tobacco flavored e-cigarette
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
menthol flavored e-cigarette
menthol flavored e-cigarette
tobacco flavored e-cigarette
tobacco flavored e-cigarette
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* smoke primarily menthol cigarettes
* be between the ages of 18 and 64
* smoke a minimum number of cigarettes per day
* agree to abstain from menthol cigarettes for an 8 week period
Exclusion Criteria
* regular use any form of nicotine or tobacco other than cigarettes
* are pregnant or breast feeding
The investigators will evaluate if there are other reasons why someone may not be eligible to participate
18 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical and Translational Sciences Institute
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1609M94682
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.